Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019
Descripción del Articulo
Objective: To determine the efficacy of the use of misoprostol for the treatment of abortions less than 12 weeks of gestation in patients attended in the Gynecology and Obstetrics emergency room of a Maternal and Child Hospital of Honduras, 2019. Material and methods: Through a descriptive study cro...
| Autores: | , , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2020 |
| Institución: | Sociedad Materno Fetal |
| Repositorio: | Revista Internacional de Salud Materno Fetal |
| Lenguaje: | español |
| OAI Identifier: | oai:ojs2.ojs.revistamaternofetal.com:article/147 |
| Enlace del recurso: | http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147 |
| Nivel de acceso: | acceso abierto |
| Materia: | Control prenatal Edad gestacional Misoprostol Aborto incompleto |
| id |
REVSMF_0fe5dee2d975bc4686fd20b26593b3b4 |
|---|---|
| oai_identifier_str |
oai:ojs2.ojs.revistamaternofetal.com:article/147 |
| network_acronym_str |
REVSMF |
| network_name_str |
Revista Internacional de Salud Materno Fetal |
| repository_id_str |
. |
| dc.title.none.fl_str_mv |
Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019 Eficacia del misoprostol como tratamiento en abortos menores a 12 semanas en un Hospital Materno Infantil de Honduras, 2019 |
| title |
Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019 |
| spellingShingle |
Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019 Martínez-Rodas, Oscar Ramón Control prenatal Edad gestacional Misoprostol Aborto incompleto |
| title_short |
Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019 |
| title_full |
Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019 |
| title_fullStr |
Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019 |
| title_full_unstemmed |
Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019 |
| title_sort |
Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019 |
| dc.creator.none.fl_str_mv |
Martínez-Rodas, Oscar Ramón Gonzáles-Castro, Gloria Mercedes Carrasco-Cerrato, Doria Aracely Parodi-Turcios, Karla Isabel |
| author |
Martínez-Rodas, Oscar Ramón |
| author_facet |
Martínez-Rodas, Oscar Ramón Gonzáles-Castro, Gloria Mercedes Carrasco-Cerrato, Doria Aracely Parodi-Turcios, Karla Isabel |
| author_role |
author |
| author2 |
Gonzáles-Castro, Gloria Mercedes Carrasco-Cerrato, Doria Aracely Parodi-Turcios, Karla Isabel |
| author2_role |
author author author |
| dc.subject.none.fl_str_mv |
Control prenatal Edad gestacional Misoprostol Aborto incompleto |
| topic |
Control prenatal Edad gestacional Misoprostol Aborto incompleto |
| description |
Objective: To determine the efficacy of the use of misoprostol for the treatment of abortions less than 12 weeks of gestation in patients attended in the Gynecology and Obstetrics emergency room of a Maternal and Child Hospital of Honduras, 2019. Material and methods: Through a descriptive study cross-sectional, prospective study, in a sample of 155 patients treated at the Tegucigalpa Maternal and Child Hospital, from May to July 2019, through a probability sampling for convenience and using a structured survey. Obstetric, pathological history, misoprostol dose, time of effectiveness, side effects or complications, and prevalence of abortions were evaluated. Results: The average maternal age that presented the highest number of cases of abortion was 24 years, with 18-29 being the most affected age group, 73.55%. In the gynecological and obstetric antecedents identified, the first-born, primiparous, and with no history of abortions prevailed; while the pathological history such as hypertensive disorders, thyroid, type 2 diabetes mellitus and immunological diseases were not significant. Conclusion: The use of misoprostol in first trimester abortions is effective; its side effects do not produce significant complications and are tolerable; the first dose being the most effective and after one day after administration for the complete expulsion of the product. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020-04-12 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Artículos de investigación que van de acuerdo a la política editorial de la revista. |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147 |
| url |
http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147 |
| dc.language.none.fl_str_mv |
spa |
| language |
spa |
| dc.relation.none.fl_str_mv |
http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147/181 |
| dc.rights.none.fl_str_mv |
Derechos de autor 2020 Revista Internacional de Salud Materno Fetal http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Derechos de autor 2020 Revista Internacional de Salud Materno Fetal http://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Sociedad Materno Fetal |
| publisher.none.fl_str_mv |
Sociedad Materno Fetal |
| dc.source.none.fl_str_mv |
Revista Internacional de Salud Materno Fetal; Vol. 6 Núm. 1 (2021); 11 - 17 International Journal of Mütterliche und fetale Gesundheit; Vol. 6 Núm. 1 (2021); 11 - 17 International Journal of Maternal and Fetal Health; Vol. 6 Núm. 1 (2021); 11 - 17 Revista Internacional de Saúde Materna e Fetal; Vol. 6 Núm. 1 (2021); 11 - 17 2519-9994 reponame:Revista Internacional de Salud Materno Fetal instname:Sociedad Materno Fetal instacron:RISMF |
| instname_str |
Sociedad Materno Fetal |
| instacron_str |
RISMF |
| institution |
RISMF |
| reponame_str |
Revista Internacional de Salud Materno Fetal |
| collection |
Revista Internacional de Salud Materno Fetal |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1846970190068187136 |
| spelling |
Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019Eficacia del misoprostol como tratamiento en abortos menores a 12 semanas en un Hospital Materno Infantil de Honduras, 2019Martínez-Rodas, Oscar RamónGonzáles-Castro, Gloria MercedesCarrasco-Cerrato, Doria AracelyParodi-Turcios, Karla IsabelControl prenatalEdad gestacionalMisoprostolAborto incompletoObjective: To determine the efficacy of the use of misoprostol for the treatment of abortions less than 12 weeks of gestation in patients attended in the Gynecology and Obstetrics emergency room of a Maternal and Child Hospital of Honduras, 2019. Material and methods: Through a descriptive study cross-sectional, prospective study, in a sample of 155 patients treated at the Tegucigalpa Maternal and Child Hospital, from May to July 2019, through a probability sampling for convenience and using a structured survey. Obstetric, pathological history, misoprostol dose, time of effectiveness, side effects or complications, and prevalence of abortions were evaluated. Results: The average maternal age that presented the highest number of cases of abortion was 24 years, with 18-29 being the most affected age group, 73.55%. In the gynecological and obstetric antecedents identified, the first-born, primiparous, and with no history of abortions prevailed; while the pathological history such as hypertensive disorders, thyroid, type 2 diabetes mellitus and immunological diseases were not significant. Conclusion: The use of misoprostol in first trimester abortions is effective; its side effects do not produce significant complications and are tolerable; the first dose being the most effective and after one day after administration for the complete expulsion of the product.Objetivo: Determinar la eficacia del uso de misoprostol para el tratamiento de abortos menores a 12 semanas de gestación en pacientes atendidas en la sala de emergencia de Ginecología y Obstetricia de un Hospital Materno Infantil de Honduras, 2019. Material y métodos: Mediante un estudio descriptivo transversal, prospectivo, en una muestra de 155 pacientes atendidas en el Hospital Materno Infantil de Tegucigalpa, durante Mayo a Julio del 2019, a través de un muestreo probabilístico por conveniencia y empleando una encuesta estructurada. Se evaluaron antecedentes obstétricos, patológicos, dosis de misoprostol, tiempo de efectividad, efectos secundarios o complicaciones y prevalencia de abortos. Resultados: La edad promedio materna que presentó mayor casos de aborto fue de 24 años, siendo 18-29 el grupo etario más afectado 73.55%. En los antecedentes gineco-obstétricos identificados prevalecieron las primigestas, primíparas y sin historia de abortos; mientras que los antecedentes patológicos como trastornos hipertensivos, tiroideos, diabetes mellitus tipo 2 y enfermedades inmunológicas no resultaron ser significativos. Conclusión: El uso del misoprostol en abortos del primer trimestre es efectivo; sus efectos secundarios no producen complicaciones significativas, y son tolerables; siendo la primera dosis la más efectiva y transcurriendo un día posterior a su administración para la expulsión completa del producto.Sociedad Materno Fetal2020-04-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtículos de investigación que van de acuerdo a la política editorial de la revista.application/pdfhttp://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147Revista Internacional de Salud Materno Fetal; Vol. 6 Núm. 1 (2021); 11 - 17International Journal of Mütterliche und fetale Gesundheit; Vol. 6 Núm. 1 (2021); 11 - 17International Journal of Maternal and Fetal Health; Vol. 6 Núm. 1 (2021); 11 - 17Revista Internacional de Saúde Materna e Fetal; Vol. 6 Núm. 1 (2021); 11 - 172519-9994reponame:Revista Internacional de Salud Materno Fetalinstname:Sociedad Materno Fetalinstacron:RISMFspahttp://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147/181Derechos de autor 2020 Revista Internacional de Salud Materno Fetalhttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:ojs2.ojs.revistamaternofetal.com:article/1472020-05-25T17:25:30Z |
| score |
12.834301 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).